Managing the continuum of treatment: modeling the economic impact of treating diabetes [0.03%]
治疗的连续体管理：建立糖尿病治疗经济效益模型
Diana I Brixner
Diana I Brixner
Objective: To describe economic models that may be useful for assessing the long-term and short-term cost-effectiveness of treatment options in the management of type 2 diabetes. ...
Patient management strategies in type 2 diabetes: current practices and future considerations [0.03%]
2型糖尿病的患者管理策略：当前实践与未来考量
Lawrence Blonde
Lawrence Blonde
Objective: To examine current issues in the management of people with type 2 diabetes, focusing on the need for early recognition, aggressive multifactorial therapy, and a systems approach to treatment in order to reduce ...
Progression from obesity to type 2 diabetes: lipotoxicity, glucotoxicity, and implications for management [0.03%]
肥胖进展为二型糖尿病：脂毒性，糖毒性及其对治疗的含义
Hal M Roseman
Hal M Roseman
Objective: To examine the roles of lipotoxicity and glucotoxicity as critical pathogenic foundations in the development of type 2 diabetes and the potential benefits of TZDs in ameliorating these processes. ...
Migraine matters: the role of triptans in relieving the burden in managed care [0.03%]
偏头痛药物治疗：曲普坦类药物在医疗管理保健中的作用
Diana I Brixner,Jan Lewis Brandes
Diana I Brixner
Objective: To provide managed care pharmacists with information regarding the prevalence and burden of migraine in the United States, approaches to diagnosing and managing migraine, and implications for managed care organ...
New concepts in diabetes: how multihormonal regulation can improve glycemic control [0.03%]
糖尿病的新概念：多重激素调节如何改善血糖控制
Lawrence Blonde,Danial E Baker,Stephen N Davis et al.
Lawrence Blonde et al.
It is estimated that 18.2 million Americans are currently living with diabetes, a disease that continues to place significant economic burdens on patients, their families, health plans, systems, and society. Recent data from the American Di...
Lessons learned from randomized trials and recent experience with health information technology: promising interventions meet real-world patient care [0.03%]
随机试验和最近应用健康信息技术的启示：有效干预措施应用于现实世界患者的护理中
Kathleen A Fairman,Frederic R Curtiss
Kathleen A Fairman
Price increases and new drugs drive increased expenditures for multiple sclerosis [0.03%]
价格与新药驱动的多发性硬化症支出增加
Jeremy A Schafer,Brent W Gunderson,Patrick P Gleason
Jeremy A Schafer
All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States [0.03%]
美国新诊断多发性硬化症的全因卫生保健利用和费用研究
Carl V Asche,Mendel E Singer,Mehul Jhaveri et al.
Carl V Asche et al.
Background: Multiple sclerosis (MS) is a costly and crippling neurologic disease. Approximately 250,000 to 400,000 persons in the United States are currently diagnosed with MS. Most individuals experience their first symp...
Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer [0.03%]
多发性骨髓瘤或转移性前列腺癌和乳腺癌患者的病理性骨折、骨手术和脊髓压迫的住院费用
Arie Barlev,Xue Song,Boris Ivanov et al.
Arie Barlev et al.
Background: Patients with bone metastasis secondary to prostate or breast cancer or multiple myeloma are predisposed to skeletal-related events (SREs), such as surgery or radiation to the bone, pathologic fracture, and sp...
Evaluation of health plan member use of an online prescription drug price comparison tool [0.03%]
健康计划成员在线处方药价格比较工具使用情况的评估
Norman V Carroll,Matthew P Mitchell,H Eric Cannon et al.
Norman V Carroll et al.
Background: Health plans have implemented tiered copayment systems to incentivize members to use less expensive medications. However, members need drug price information to make comparisons among therapeutic alternatives....